Formula IV Plus - New, NeoLife International Pty Ltd, CON-693
Product name
Formula IV Plus - New
Sponsor name
NeoLife International Pty Ltd
Consent start
Consent no.
CON-693
Standard
Sub-paragraphs 10(8)(a)(vi) and 10(8)(a)(vii) of Therapeutic Goods Order No. 92 - Standard for labels of non-prescription medicines
Non-compliance with standard
The product does not conform in that the individual unit wrapper (intermediate
packaging) does not include the names and quantities of all active ingredients
in the medicine.
Conditions imposed
The outer carton (primary packaging) must include a statement indicating that
each individually wrapped unit must be kept inside the carton prior to the time
of consumption. You may choose the following statements on your labels or
wordings along those lines. 'Do not remove from primary packaging before use';
or 'Store in original outer packaging until use'
Therapeutic product type
Listed complementary medicines